Constitutive Androstane Receptor: A Peripheral and a Neurovascular Stress or Environmental Sensor.
blood-brain barrier, stress sensor
brain
constitutive androstane receptor
environmental contaminants
liver
neurovascular unit
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
06 11 2020
06 11 2020
Historique:
received:
06
10
2020
revised:
27
10
2020
accepted:
02
11
2020
entrez:
11
11
2020
pubmed:
12
11
2020
medline:
17
6
2021
Statut:
epublish
Résumé
Xenobiotic nuclear receptors (NR) are intracellular players involved in an increasing number of physiological processes. Examined and characterized in peripheral organs where they govern metabolic, transport and detoxification mechanisms, accumulating data suggest a functional expression of specific NR at the neurovascular unit (NVU). Here, we focus on the Constitutive Androstane Receptor (CAR), expressed in detoxifying organs such as the liver, intestines and kidneys. By direct and indirect activation, CAR is implicated in hepatic detoxification of xenobiotics, environmental contaminants, and endogenous molecules (bilirubin, bile acids). Importantly, CAR participates in physiological stress adaptation responses, hormonal and energy homeostasis due to glucose and lipid sensing. We next analyze the emerging evidence supporting a role of CAR in NVU cells including the blood-brain barrier (BBB), a key vascular interface regulating communications between the brain and the periphery. We address the emerging concept of how CAR may regulate specific P450 cytochromes at the NVU and the associated relevance to brain diseases. A clear understanding of how CAR engages during pathological conditions could enable new mechanistic, and perhaps pharmacological, entry-points within a peripheral-brain axis.
Identifiants
pubmed: 33171992
pii: cells9112426
doi: 10.3390/cells9112426
pmc: PMC7694609
pii:
doi:
Substances chimiques
Constitutive Androstane Receptor
0
Receptors, Cytoplasmic and Nuclear
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Drug Metab Dispos. 2014 Aug;42(8):1235-40
pubmed: 24832206
Curr Drug Metab. 2011 Oct;12(8):742-9
pubmed: 21568937
Mol Pharmacol. 2002 Jan;61(1):1-6
pubmed: 11752199
Drug Metab Dispos. 2017 Aug;45(8):977-981
pubmed: 28546505
Nature. 2000 Oct 19;407(6806):920-3
pubmed: 11057673
J Biol Chem. 2002 Jul 19;277(29):26356-63
pubmed: 12000748
Cancer Sci. 2006 Nov;97(11):1260-6
pubmed: 16925582
Neurobiol Dis. 2010 Jan;37(1):13-25
pubmed: 19664713
J Biol Chem. 2006 Jun 16;281(24):16625-31
pubmed: 16606610
Mol Cell Biol. 1999 Sep;19(9):6318-22
pubmed: 10454578
Toxicol Appl Pharmacol. 2006 Sep 15;215(3):274-84
pubmed: 16730040
Toxicol Sci. 2009 Jan;107(1):93-105
pubmed: 18832183
J Biochem Mol Toxicol. 2006;20(6):309-17
pubmed: 17163485
PLoS One. 2011;6(6):e21229
pubmed: 21698271
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18831-6
pubmed: 19850873
Toxicol Sci. 2019 Jan 1;167(1):282-292
pubmed: 30247703
Mol Endocrinol. 2015 Nov;29(11):1558-70
pubmed: 26407237
Mol Pharmacol. 2006 Jul;70(1):329-39
pubmed: 16608920
Toxicology. 2014 Jul 3;321:80-8
pubmed: 24675475
Mol Cell Biol. 2004 Sep;24(18):7931-40
pubmed: 15340055
Clin Pharmacokinet. 2003;42(15):1331-57
pubmed: 14674787
Mol Pharmacol. 2002 Sep;62(3):638-46
pubmed: 12181440
Brain Res. 2013 Mar 21;1501:68-80
pubmed: 23340159
Mol Pharmacol. 2003 Aug;64(2):474-81
pubmed: 12869653
Toxicol Lett. 2013 May 23;219(2):143-50
pubmed: 23528251
Xenobiotica. 2011 Jul;41(7):519-29
pubmed: 21476904
Toxicology. 2009 Feb 4;256(1-2):53-64
pubmed: 19041682
ACS Med Chem Lett. 2019 Jun 12;10(7):1039-1044
pubmed: 31312405
Drug Metab Pharmacokinet. 2004 Apr;19(2):135-49
pubmed: 15499180
Mol Cell Biol. 2000 May;20(9):2951-8
pubmed: 10757780
Mol Cell Biol. 2014 Feb;34(3):485-97
pubmed: 24277929
Mol Pharmacol. 2000 Dec;58(6):1441-50
pubmed: 11093784
Life Sci. 2007 Feb 13;80(10):910-7
pubmed: 17161434
Biochemistry. 2007 Jan 23;46(3):862-70
pubmed: 17223708
J Biol Chem. 2000 May 19;275(20):15122-7
pubmed: 10748001
Pharmacogenomics J. 2002;2(2):117-26
pubmed: 12049174
J Lipid Res. 2006 Feb;47(2):241-59
pubmed: 16299351
Drug Metab Dispos. 2009 May;37(5):1035-45
pubmed: 19196849
Toxicol Appl Pharmacol. 2015 Apr 15;284(2):188-96
pubmed: 25703434
Epilepsy Behav. 2011 Feb;20(2):382-5
pubmed: 21256090
Mol Pharmacol. 2008 Apr;73(4):1113-21
pubmed: 18202305
Drug Metab Dispos. 2009 Jul;37(7):1528-38
pubmed: 19359404
J Biol Chem. 2004 Jul 9;279(28):29295-301
pubmed: 15123723
Science. 2002 Oct 11;298(5592):422-4
pubmed: 12376703
Mol Endocrinol. 2004 Oct;18(10):2402-8
pubmed: 15272053
Endocrinology. 2010 Apr;151(4):1653-61
pubmed: 20185760
J Biol Chem. 2009 Dec 11;284(50):34785-92
pubmed: 19858220
J Biol Chem. 2004 Nov 19;279(47):49517-22
pubmed: 15358766
Mol Pharmacol. 2013 Nov;84(5):774-86
pubmed: 24019224
Mol Pharmacol. 2004 Jun;65(6):1397-404
pubmed: 15155833
J Steroid Biochem Mol Biol. 1992 Dec;43(8):1023-30
pubmed: 22217846
Mol Cell Biol. 1994 Mar;14(3):1544-52
pubmed: 8114692
Gut. 2004 Apr;53(4):542-8
pubmed: 15016749
Mol Pharmacol. 2005 Jun;67(6):1954-65
pubmed: 15761118
Mol Neurobiol. 2019 May;56(5):3113-3131
pubmed: 30097849
Biochem Pharmacol. 2015 Nov 1;98(1):190-202
pubmed: 26275810
Cell Metab. 2007 Jan;5(1):73-9
pubmed: 17189208
Nature. 1998 Oct 8;395(6702):612-5
pubmed: 9783588
Biochem Biophys Res Commun. 2002 Mar 29;292(2):492-7
pubmed: 11906189
J Biol Chem. 2004 May 7;279(19):19832-8
pubmed: 15004031
Mol Endocrinol. 2004 Jul;18(7):1589-98
pubmed: 14988430
Heliyon. 2019 Sep 12;5(9):e02466
pubmed: 31538121
Toxicol Appl Pharmacol. 2014 Aug 15;279(1):33-42
pubmed: 24878338
Br J Pharmacol. 2020 Jun;177(12):2666-2682
pubmed: 32201941
Expert Opin Drug Metab Toxicol. 2010 Apr;6(4):409-26
pubmed: 20113149
Mol Pharmacol. 2004 Feb;65(2):292-300
pubmed: 14742670
Mol Endocrinol. 2003 Jan;17(1):42-55
pubmed: 12511605
Mol Pharmacol. 2009 May;75(5):1005-13
pubmed: 19211671
Drug Metab Dispos. 2001 Jun;29(6):781-5
pubmed: 11353743
Toxicol Appl Pharmacol. 2016 Jul 15;303:90-100
pubmed: 27180240
Physiol Rev. 2019 Jan 1;99(1):21-78
pubmed: 30280653
World J Gastroenterol. 2014 Jul 21;20(27):8764-82
pubmed: 25083051
Hepatology. 2003 Aug;38(2):314-25
pubmed: 12883475
J Biol Chem. 2003 Oct 10;278(41):39653-61
pubmed: 12900407
Toxicol Sci. 2019 Mar 1;168(1):40-60
pubmed: 30407581
J Biol Chem. 1999 Mar 5;274(10):6043-6
pubmed: 10037683
Hepatology. 2001 May;33(5):1232-8
pubmed: 11343253
Mol Pharmacol. 2018 Mar;93(3):239-250
pubmed: 29351922
J Biol Chem. 2000 Feb 11;275(6):4345-50
pubmed: 10660604
FEBS Lett. 2007 Dec 11;581(29):5617-26
pubmed: 18023279
Clin Sci (Lond). 2018 Feb 8;132(3):361-374
pubmed: 29439117
Front Aging Neurosci. 2020 Feb 04;12:3
pubmed: 32116645
Arch Toxicol. 2017 Jun;91(6):2365-2374
pubmed: 27832320
Curr Pharmacogenomics Person Med. 2009 Jun 1;7(2):81-105
pubmed: 20871735
Exp Neurol. 2016 Sep;283(Pt A):39-48
pubmed: 27240521
J Biol Chem. 2006 Sep 8;281(36):26540-51
pubmed: 16825189
Toxicol Sci. 2008 Nov;106(1):29-36
pubmed: 18648086
Mol Cell. 2004 Dec 22;16(6):907-17
pubmed: 15610734
J Biol Chem. 2006 May 26;281(21):14537-46
pubmed: 16492670
Toxicol Lett. 2005 Dec 15;159(3):203-11
pubmed: 16188404
Handb Clin Neurol. 2014;120:595-605
pubmed: 24365340
Pharmacol Biochem Behav. 2004 Jun;78(2):285-91
pubmed: 15219769
J Biol Chem. 2003 Mar 28;278(13):11344-50
pubmed: 12551939
Nucl Recept Signal. 2015 Apr 27;13:e002
pubmed: 25949234
Bull Exp Biol Med. 2007 Sep;144(3):338-41
pubmed: 18457031
Br J Pharmacol. 2003 Jun;139(4):787-96
pubmed: 12813002
J Steroid Biochem Mol Biol. 2016 Feb;156:43-52
pubmed: 26643981
Endocr Rev. 1991 May;12(2):135-50
pubmed: 2070777
Drug Metab Dispos. 2006 Dec;34(12):2003-10
pubmed: 16936065
Biochem J. 2007 Feb 1;401(3):735-41
pubmed: 17032173
Chem Res Toxicol. 2012 Apr 16;25(4):811-24
pubmed: 22303888
J Biol Chem. 2009 Sep 18;284(38):25984-92
pubmed: 19617349
Mol Neurobiol. 2017 Jul;54(5):3633-3651
pubmed: 27206429
Mol Cell. 2004 Dec 22;16(6):919-28
pubmed: 15610735
Toxicology. 2005 Oct 15;214(1-2):113-22
pubmed: 16039771
Sci Rep. 2019 Dec 27;9(1):20169
pubmed: 31882815
Clin Pharmacol Ther. 1983 Jun;33(6):826-35
pubmed: 6851415
Br J Cancer. 2011 Feb 1;104(3):448-59
pubmed: 21224854
Mol Pharmacol. 2010 Sep;78(3):376-83
pubmed: 20547735
Eur J Cancer Prev. 2014 Jan;23(1):1-7
pubmed: 23492954
Mol Pharmacol. 2008 Aug;74(2):443-53
pubmed: 18492798
Biochem Pharmacol. 2019 Oct;168:224-236
pubmed: 31306645
Endocrinol Metab (Seoul). 2016 Dec;31(4):519-524
pubmed: 28029023
Physiol Behav. 2012 Aug 20;107(1):26-33
pubmed: 22634281
FEBS Lett. 2009 Mar 4;583(5):885-9
pubmed: 19302787
PLoS Genet. 2017 Oct 25;13(10):e1006864
pubmed: 29069077
Endocrinology. 2005 Mar;146(3):995-1002
pubmed: 15564320
J Pharmacol Exp Ther. 2002 Jan;300(1):206-12
pubmed: 11752118
J Biol Chem. 2003 May 9;278(19):17277-83
pubmed: 12611900
Int J Mol Sci. 2018 Jul 28;19(8):
pubmed: 30060580
Chem Res Toxicol. 2016 Oct 17;29(10):1651-1661
pubmed: 27551952
Clin Pharmacol Ther. 2007 Sep;82(3):265-74
pubmed: 17344806
Br J Pharmacol. 2017 Jun;174(12):1857-1871
pubmed: 28320072
Toxicol Sci. 2007 Sep;99(1):315-25
pubmed: 17557908
Toxicol Sci. 2005 Aug;86(2):281-90
pubmed: 15901914
Drug Metab Dispos. 2017 Aug;45(8):974-976
pubmed: 28536098
Chem Biol Interact. 1998 Feb 20;109(1-3):279-91
pubmed: 9566752
Diabetes. 1985 Sep;34(9):911-6
pubmed: 3896900
Toxicology. 2012 Mar 11;293(1-3):16-29
pubmed: 22245121
Adv Cancer Res. 2015;125:43-70
pubmed: 25640266
J Neurochem. 2011 Jul;118(2):163-75
pubmed: 21517853
Mol Pharmacol. 2002 Aug;62(2):366-78
pubmed: 12130690
Drug Metab Dispos. 2007 Jul;35(7):1032-41
pubmed: 17392393
Brain Behav Immun. 2017 Feb;60:1-12
pubmed: 26995317
Fluids Barriers CNS. 2013 Mar 26;10(1):16
pubmed: 23531482
FEBS Lett. 2003 Jul 31;548(1-3):17-20
pubmed: 12885400
Toxicol Sci. 2015 Oct;147(2):436-45
pubmed: 26160115
J Pharmacol Exp Ther. 2004 Nov;311(2):811-21
pubmed: 15194709